GILEAD SCIENCES, INC. Increase (Decrease) in Deferred Income Taxes
GILEAD SCIENCES, INC. (GILD) reported Increase (Decrease) in Deferred Income Taxes of $116.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2022-02-23
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-12-31 was $24.00M.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-09-30 was -$21.00M, a 111.54% decline year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-06-30 was $131.00M, a 5.76% decline year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for the quarter ending 2016-03-31 was -$15.00M, a 112.40% decline year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2021 was $116.00M, a 45.79% decline from fiscal 2020.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2020 was $214.00M, a 89.80% decline from fiscal 2019.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2019 was $2.10B.
- GILEAD SCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2018 was -$289.00M, a 452.44% decline from fiscal 2017.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 3 month as first filed | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 6 month as first filed | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 9 month as first filed | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $116.00M 10-K · filed 2022-02-23 | |||||||
| 2020-12-31 | $214.00M 10-K · filed 2022-02-23 | |||||||
| 2019-12-31 | $2.10B 10-K · filed 2022-02-23 | |||||||
| 2018-12-31 | -$289.00M 10-K · filed 2021-02-25 | |||||||
| 2017-12-31 | $82.00M 10-K · filed 2020-02-25 | |||||||
| 2016-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.00M derived: sum of 2 quarters · filed 2019-02-26 | $134.00M derived: sum of 3 quarters · filed 2019-02-26 | $119.00M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $110.00M derived: sum of 2 quarters · filed 2016-11-07 | $95.00M 10-Q · filed 2016-11-07 | $46.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $131.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $116.00M 10-Q · filed 2016-08-05 | $67.00M derived: sum of 3 quarters · filed 2018-02-27 | $249.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$15.00M 10-Q · filed 2016-05-06 | -$64.00M derived: sum of 2 quarters · filed 2018-02-27 | $118.00M derived: sum of 3 quarters · filed 2018-02-27 | $257.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $133.00M derived: sum of 2 quarters · filed 2018-02-27 | $272.00M derived: sum of 3 quarters · filed 2018-02-27 | $393.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $182.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $321.00M derived: sum of 2 quarters · filed 2016-11-07 | $442.00M 10-Q · filed 2016-11-07 | $611.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $139.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $260.00M 10-Q · filed 2016-08-05 | $429.00M derived: sum of 3 quarters · filed 2017-02-27 | $443.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $121.00M 10-Q · filed 2016-05-06 | $290.00M derived: sum of 2 quarters · filed 2017-02-27 | $304.00M derived: sum of 3 quarters · filed 2017-02-27 | $354.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $169.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $183.00M derived: sum of 2 quarters · filed 2017-02-27 | $233.00M derived: sum of 3 quarters · filed 2017-02-27 | $236.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $64.00M derived: sum of 2 quarters · filed 2015-11-04 | $67.00M 10-Q · filed 2015-11-04 | $67.06M 10-Q · filed 2014-11-05 | $152.60M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $53.00M 10-Q · filed 2015-08-05 | $53.54M 10-Q · filed 2014-08-04 | $138.60M derived: sum of 3 quarters · filed 2016-02-24 | $160.97M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $3.00M 10-Q · filed 2015-05-08 | $3.32M 10-Q · filed 2014-05-07 | $88.60M derived: sum of 2 quarters · filed 2016-02-24 | $110.97M derived: sum of 3 quarters · filed 2016-02-24 | $140.30M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $85.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $107.97M derived: sum of 2 quarters · filed 2016-02-24 | $137.30M derived: sum of 3 quarters · filed 2016-02-24 | $98.00M 10-K · filed 2016-02-24 | $98.18M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $22.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $51.70M derived: sum of 2 quarters · filed 2014-11-05 | $12.40M 10-Q · filed 2014-11-05 | $72.77M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $29.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$9.97M 10-Q · filed 2014-08-04 | $50.40M derived: sum of 3 quarters · filed 2015-02-25 | $50.99M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | -$39.30M 10-Q · filed 2014-05-07 | $21.07M derived: sum of 2 quarters · filed 2015-02-25 | $21.66M derived: sum of 3 quarters · filed 2015-02-25 | $51.08M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $60.37M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $60.97M derived: sum of 2 quarters · filed 2015-02-25 | $90.39M derived: sum of 3 quarters · filed 2015-02-25 | $39.00M 10-K · filed 2015-02-25 | $39.39M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $30.01M derived: sum of 2 quarters · filed 2013-10-31 | -$21.37M 10-Q · filed 2013-10-31 | -$42.02M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $29.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$21.97M 10-Q · filed 2013-08-01 | -$42.61M derived: sum of 3 quarters · filed 2014-02-25 | -$46.02M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$51.38M 10-Q · filed 2013-05-08 | -$72.03M derived: sum of 2 quarters · filed 2014-02-25 | -$75.44M derived: sum of 3 quarters · filed 2014-02-25 | -$94.90M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$20.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$24.05M derived: sum of 2 quarters · filed 2014-02-25 | -$43.52M derived: sum of 3 quarters · filed 2014-02-25 | -$64.06M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$22.87M derived: sum of 2 quarters · filed 2012-11-06 | -$43.41M 10-Q · filed 2012-11-06 | -$12.85M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | -$19.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$40.01M 10-Q · filed 2012-08-01 | -$9.44M derived: sum of 3 quarters · filed 2013-02-27 | |||||
| 2011-03-31 | -$20.55M 10-Q · filed 2012-05-04 | $10.02M derived: sum of 2 quarters · filed 2013-02-27 | ||||||
| 2010-12-31 | $30.57M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$12.15M 10-K · filed 2013-02-27 | ||||||
| 2010-09-30 | -$42.72M 10-Q · filed 2011-11-04 | |||||||
| 2009-12-31 | $42.01M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |